AstraZeneca saw 18% revenue growth in 2024, boosted by key drugs and global innovation. See here to know why we recommend a ...
Pharmaceutical giant AstraZeneca announced its fourth quarter ... Renal and Metabolism (CVRM) total revenue jumped 20%.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback